Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438783
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-27
Brief Title:
TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in RecurrentMetastatic Osteosarcoma and Other Solid Tumors
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization Data
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Class:
INDUSTRY
Study ID:
TQB2928-ALTN-Ib-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None